Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 · New England Journal of Medicine · 21K citations
https://doi.org/10.1056/nejmoa043330
R
R.O. Mirimanoff
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
120
Papers
35.6K
Citations
33
h-index
53
i10-index
R.O. Mirimanoff is an academic researcher from University Hospital of Lausanne. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Brain Metastases and Treatment & Head and Neck Cancer Studies. The author has an h-index of 33, co-authored 102 publications.
Papers by this author
works<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
2005 · New England Journal of Medicine · 7,163 citations
https://doi.org/10.1056/nejmoa043331
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
2007 · The Lancet Oncology · 543 citations
https://doi.org/10.1016/s1470-2045(07)70384-4
Patterns of Failure and Outcome in Patients with Carcinoma of the Anal Margin
2008 · Annals of Surgical Oncology · 29 citations
https://doi.org/10.1245/s10434-007-9794-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat